Artificial Pancreas Device System Forecast Report – Designed for Decision Makers and Product Teams
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Artificial Pancreas Device System Market In 2029?
In recent times, the artificial pancreas device system market has seen a swift expansion. The market size is anticipated to rise from $1.81 billion in 2024 to $2.07 billion in 2025, with a compound annual growth rate (CAGR) of 14.1%. The previously observed growth is owing to factors such as increased investment inflow, growing governmental initiatives in clinical research, a rising demand for automated systems for glycemic control, heightened R&D activities by industry stakeholders, and the surge in the elderly population.
What Growth Rate Is Forecasted for the Artificial Pancreas Device System Market by 2029?
The market size of the artificial pancreas device system is predicted to increase dramatically in the upcoming years, reaching $3.48 billion in 2029 with a compound annual growth rate (CAGR) of 13.9%. This growth projected for the forecasted period is due to the rising incidence of diabetes, the growing prevalence of pancreatic cancer, an increase in occurrences of diabetes and obesity, a growing demand for minimally invasive (MI) drug delivery systems, and improvements in diabetes management technology. Key trends for the forecast period encompass technological advancements, heightened research and development efforts, an increase in product approvals, collaborations and partnerships, and a rise in teleconsultancy activities for follow-ups.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
Which Key Companies Are Shaping the Future of the Artificial Pancreas Device System Market?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd
Which Factors Are Driving Demand in the Artificial Pancreas Device System Industry?
The artificial pancreas device system market is predicted to experience growth driven by the rising rate of pancreatic cancer. This type of cancer, which is a malignant tumor that forms in the pancreas, a gland situated behind the stomach, is influenced by an assortment of factors including lifestyle, genetics, medical and environmental aspects, as well as genetic mutations that cause hereditary pancreatitis, resulting in chronic inflammation of the pancreas. An artificial pancreas device system (APDS) is primarily engineered to assist people with diabetes in regulating their blood sugar levels by automatically tracking glucose and administering the necessary insulin dosage. For example, in March 2024, the government agency, Cancer Australia, projected that there were 4,506 new diagnoses of pancreatic cancer in 2023, demonstrating an increase from the 3,751 cases documented over the last five years. Hence, the growing incidence of pancreatic cancer is fueling the expansion of the artificial pancreas device system market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
How Is the Artificial Pancreas Device System Market Segmented by Several Divisions?
The artificial pancreas device system market covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems, Control-To-Range Systems, Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal, Insulin Only, Hybrid
3) By End-User: Hospitals, Medical Centers, Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend, Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems, Insulin Delivery Systems with Range Control, Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems, Insulin Pumps with Targeted Glucose Control, Automated Glucose Regulation Systems
What are the Emerging Market Trends Driving the Growth of the Artificial Pancreas Device System Industry?
Leading firms in the artificial pancreas device system market are focusing on the creation of automated insulin delivery solutions to improve diabetes control by autonomously tracking glucose levels in the blood and providing the necessary insulin dosage. The aim of these automated insulin delivery systems is to mimic the operational capabilities of a healthy pancreas, thereby alleviating the need for continuous blood sugar checks and manual insulin dosing for people living with diabetes. For example, Beta Bionics, a medical equipment manufacturer based in the US, obtained FDA 510(k) approval in May 2023 for their iLet Insulin-Only Bionic Pancreas System, a device that delivers insulin automatically. This artificial pancreas system is engineered to independently determine and administer insulin dosage to regulate glucose levels in the blood. It operates as a closed-loop system that modifies insulin delivery relying on the user’s glucose levels recorded by an attached continuous glucose monitor (CGM). The system only needs the user’s weight and an estimate of meal size to automatically adjust insulin delivery.
Access The Full Report Here:
Which Regions Are Driving Growth in the Artificial Pancreas Device System Market?
North America was the largest region in the artificial pancreas device system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18229
This Report Delivers Insight On:
1. How big is the artificial pancreas device system market, and how is it changing globally?
2. Who are the major companies in the artificial pancreas device system market, and how are they performing?
3. What are the key opportunities and risks in the artificial pancreas device system market right now?
4. Which products or customer segments are growing the most in the artificial pancreas device system market?
5. What factors are helping or slowing down the growth of the artificial pancreas device system market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
